Halliburton Labs has announced the addition of three clean energy tech companies. Photo courtesy of Halliburton

Halliburton has again added a handful of energy tech startups to its Houston-based incubator.

Three companies — Matrix Sensors, Renew Power Systems, and SunGreenH2 — have joined Halliburton Labs as its newest clean energy participants.

“Companies across the energy landscape are interested in scalable innovations that improve the cost, reliability, and sustainability of energy,” says Managing Director Dale Winger in the news release. “Our tailored program combines expert support, access to a global network, and the physical resources for participants to scale. We’re excited to help these companies accelerate their market traction.”

Halliburton, a provider of energy equipment and services, launched Halliburton Labs in 2020. Last September was the incubator's last cohort addition. The next Halliburton Labs Finalists Pitch Day is Friday, January 27, at the Ion. The event will include pitches from 10 innovative, early-stage energy tech companies. Registration is open for the event.

Here are details, according to Halliburton, about the three new startups at the incubator.

Matrix Sensors

Using a new class of gas-adsorbing materials known as metal-organic frameworks to develop the world’s first quantitative gas sensor on a chip, Matrix Sensors has created a touch-free technology that enables advancements in sensor size, power, cost, and performance to address limitations of current gas sensor technologies, which require manual calibration every six months. The company is based in San Diego, California.

“With Halliburton’s global reach, we can apply our technology to some of the biggest problems facing the energy sector today, including CO2 sensors for energy efficient buildings and methane sensors for leak detection,” says Matrix Sensors CEO Steve Yamamoto in the release.

Renew Power Systems

RPSi, based in Minneapolis, Minnesota, is a clean-tech company that develops hardware and software solutions that enable flexible and sustainable grid infrastructure. RPSi uses power electronics to connect renewable energy resources, such as wind and solar, with each other and the grid.

“Our mission is to help change the way the world generates and distributes energy,” says CEO Zach Emond in the release. “With RPSi technology, a diverse range of domestic and global communities will benefit from the acceleration of renewable energy resources that work with new and existing grid infrastructure and improve access to affordable, sustainable, and resilient electricity.”

SunGreenH2

Singapore-based SunGreenH2 builds high-performance hardware for electrolyzer cells, stacks, and systems that increase hydrogen production, decrease energy use, and reduce platinum group metals use. The company supplies hardware components for alkaline and proton-exchange membrane electrolyzers. Its modular, high-efficiency anion exchange membrane (AEM) electrolyzer stack, which is being commercialized, uses renewable power to produce low-cost green hydrogen for industries, transport, and energy storage.

“We are excited to unlock the future of green hydrogen production. With the help of Halliburton’s engineering and manufacturing expertise, we plan to commercialize and roll out our product in major international markets,” says Tulika Raj, co-founder and CEO of the company, in the release.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.